345
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Determinants of Drug-Resistant Tuberculosis in Southern Ethiopia: A Case–Control Study

& ORCID Icon
Pages 1823-1829 | Published online: 16 Jun 2020

References

  • WHO. Global Tuberculosis Report 2019. Geneva, Swizerland: World Health Organization; 2019.
  • WHO. Multidrug and Extensively Drug-Resistant TB 2010 Global Report on Surveillance and Response. World Health Organization; 2010.
  • Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and drug resistance patterns of mycobacterium tuberculosis among new smear positive pulmonary tuberculosis patients in Eastern Ethiopia. Tuberc Res Treat. 2014;2014:1–7. doi:10.1155/2014/753492
  • Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of Metema and West Armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15:461. doi:10.1186/s12879-015-1202-726503269
  • Hordofa MW, Adela TB. Prevalence of rifampicin mono resistant mycobacterium tuberculosis among suspected cases attending at Yirgalem Hospital. Clin Med Res. 2015;4(3):75–78. doi:10.11648/j.cmr.20150403.13
  • Hirpa S, Medhin G, Girma B, et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013;13:782. doi:10.1186/1471-2458-13-78223981845
  • Biadglegne F, Sack U, Rodloff AC. Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. Antimicrob Resist Infect Control. 2014;3(31). doi:10.1186/2047-2994-3-31
  • Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57–61. doi:10.1016/j.ijid.2015.08.01326327121
  • Esmael A, Ali I, Agonafir M, et al. Drug resistance pattern of mycobacterium tuberculosis in Eastern Amhara Regional State, Ethiopia. J Microb Biochem Technol. 2014;6:75–79. doi:10.4172/1948-5948.1000125
  • Zhang C, Wang Y, Shi G, et al. Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study. BMC Public Health. 2016;16:42. doi:10.1186/s12889-016-2711-z26775263
  • Liu Q, ZhuL L, Shao Y, et al. Rates and risk factors for drug resistance tuberculosis in Northeastern China. BMC Public Health. 2013;13:1171. doi:10.1186/1471-2458-13-117124330553
  • Faustini AJHA, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe. US Natl Lib Med. 2006;61(2):158–163.
  • Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtjorn B. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. BMC Public Health. 2016;16:593. doi:10.1186/s12889-016-3210-y27430266
  • Zhao P, Li XJ, Zhang SF, Wang XS, Liu CY. Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis. J Int Med Res. 2012;40:436–445. doi:10.1177/14732300120400020522613404
  • Meriki HD, Tufon KA, Atanga PN, et al. Drug resistance profiles of mycobacterium tuberculosis complex and factors associated with drug resistance in the Northwest and Southwest Regions of Cameroon. PLoS One. 2013;8(10):e77410. doi:10.1371/journal.pone.007741024146991
  • Elmi OS, Hasan H, Abdullah S, Jeab MZM, Alwi ZB, Naing NN. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. J Infect Dev Ctries. 2015;9(10):1076–1085. doi:10.3855/jidc.616226517482
  • Zetola NM, Modongo C, Kip EC, Gross R, Bisson GP, Collman RG. Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana. Int J Tuberc Lung Dis. 2012;16(11):1529–1534. doi:10.5588/ijtld.12.002622963934
  • Mulu W, Mekkonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci. 2015;15(2):368. doi:10.4314/ahs.v15i2.926124781
  • Skrahina A, Hurevich H, Zalutskaya A, et al. Multidrug-resistant tuberculosis in Belarus. Bull World Health Organ. 2013;91(1):36–45. doi:10.2471/BLT.12.10458823397349
  • Ahmad AM, Akhtar S, Hasan R, Khan JA, Hussain SF, Rizvi N. Risk factors for multidrug-resistant tuberculosis in urban Pakistan: a multicenter case-control study. Int J Mycobacteriol. 2012;1(3):137–142. doi:10.1016/j.ijmyco.2012.07.00726787209
  • WHO. Global Tuberculosis Report. Geneva, Swtherland: World Health Organization; 2015.
  • CSA. Population Projection of Ethiopia for All Regions at Wereda Level from 2014 – 2017. Addis Ababa: Central Statistical Agency; 2013.
  • Demelash A, Berhanu S, Lemessa O. Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2017;10:209–213.28744149
  • Abdulhalik W, Wondwosen K, Fessahaye A. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Infect Drug Resist. 2017;10:10 91–96.
  • Gebremichael LE, Abay SO, Subas CH. Anti-tuberculosis drug resistance in Ethiopia meta-analysis. J Drug Deliv Ther. 2014;4(3):154–163. doi:10.22270/jddt.v4i3.863
  • Elduma AH, Mansournia MA, Foroushani AR, et al. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study. Epidemiol Health. 2019;41:e2019014. doi:10.4178/epih.e201901431010280
  • Abdela K, Abdisa K, Kebede W, Abebe G. Drug resistance patterns of mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma. BMC Public Health. 2015;15:599. doi:10.1186/s12889-015-1955-326135909
  • Philip MRFH, Surbhi MO, Rosalia IN, Abbas ZE, Lauren AL. Multidrug-resistant tuberculosis in Namibia. BMC Infect Dis. 2012;12. doi:10.1186/1471-2334-12-166
  • Lukoye D, Ssengooba W, Musisi K, et al. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2015;15:291. doi:10.1186/s12889-015-1614-825880829